LexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health

BEVERLY, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to announce a large veterinary animal health corporation has purchased 2 MiQLab® Systems for two of their locations. Both locations will use the MiQLab Systems for fast evidence-based decision making at the point of care.